| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 49.5752 | 47 |
| GSM780708 | Untreated after 4 days (C2_1) | 41.0543 | 10 |
| GSM780709 | Untreated after 4 days (C3_1) | 45.2345 | 28 |
| GSM780719 | Untreated after 4 days (C1_2) | 48.0827 | 41 |
| GSM780720 | Untreated after 4 days (C2_2) | 54.7478 | 59 |
| GSM780721 | Untreated after 4 days (C3_2) | 48.4812 | 43 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 46.8741 | 36 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 41.853 | 13 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 45.608 | 30 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 46.6322 | 35 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 47.528 | 39 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 48.9696 | 45 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 46.4017 | 34 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 46.2244 | 33 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 47.8246 | 40 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 40.5686 | 8 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 48.9659 | 45 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 47.5536 | 39 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 41.1296 | 10 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 46.7075 | 35 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 48.0593 | 41 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 49.1708 | 46 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 47.1891 | 38 |